| Authors: |
Leapman MS; Department of Urology, Yale School of Medicine, New Haven, Connecticut.; Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven, Connecticut.; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut., Rothen J; Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven, Connecticut.; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut., Long JB; Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven, Connecticut.; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut., Kim IE; Department of Urology, Stanford School of Medicine, Stanford, California., Mitchell AE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Yu JB; Department of Radiation Oncology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire., Dinan MA; Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven, Connecticut.; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut., Gross CP; Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven, Connecticut.; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut.; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut., Ma X; Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven, Connecticut.; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut. |
